Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration.

Agusti A, Faner R, Donaldson G, Heuvelin E, Breyer-Kohansal R, Melén E, Maitland-van der Zee AH, Vestbo J, Allinson JP, Vanfleteren LEGW, van den Berge M, Adcock IM, Lahousse L, Brusselle G, Wedzicha JA; on behalf of the CADSET Clinical Research Collaboration; Current members of the CADSET Clinical Research Collaboration.

Eur Respir J. 2019 Mar 18;53(3). pii: 1900217. doi: 10.1183/13993003.00217-2019. Print 2019 Mar. No abstract available.

PMID:
30886026
2.

Immunotherapy in Non-Small Cell Lung Cancer. Which Patients and at Which Stage?

Allinson JP, Brown J, Gibb K, Navani N.

Am J Respir Crit Care Med. 2019 May 15;199(10):1277-1279. doi: 10.1164/rccm.201810-1930RR. No abstract available.

PMID:
30860861
3.

Childhood Exposures, Asthma, Smoking, Interactions, and the Catch-Up Hypothesis.

Allinson JP, Hardy R, Donaldson GC, Wedzicha JA.

Ann Am Thorac Soc. 2018 Oct;15(10):1241-1242. doi: 10.1513/AnnalsATS.201807-444LE. No abstract available.

4.

Clinical biomarker validation.

Allinson JL.

Bioanalysis. 2018 Jun 1;10(12):957-968. doi: 10.4155/bio-2018-0061. Epub 2018 Jun 20. Review.

PMID:
29923754
5.

At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Martinez FJ, Han MK, Allinson JP, Barr RG, Boucher RC, Calverley PMA, Celli BR, Christenson SA, Crystal RG, Fagerås M, Freeman CM, Groenke L, Hoffman EA, Kesimer M, Kostikas K, Paine R 3rd, Rafii S, Rennard SI, Segal LN, Shaykhiev R, Stevenson C, Tal-Singer R, Vestbo J, Woodruff PG, Curtis JL, Wedzicha JA.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1540-1551. doi: 10.1164/rccm.201710-2028PP. No abstract available. Erratum in: Am J Respir Crit Care Med. 2018 Dec 1;198(11):1463.

6.

Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.

Wang Z, Singh R, Miller BE, Tal-Singer R, Van Horn S, Tomsho L, Mackay A, Allinson JP, Webb AJ, Brookes AJ, George LM, Barker B, Kolsum U, Donnelly LE, Belchamber K, Barnes PJ, Singh D, Brightling CE, Donaldson GC, Wedzicha JA, Brown JR; COPDMAP.

Thorax. 2018 Apr;73(4):331-338. doi: 10.1136/thoraxjnl-2017-210741. Epub 2017 Dec 21.

7.

Update in Chronic Obstructive Pulmonary Disease 2016.

Allinson JP, Wedzicha JA.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):414-424. doi: 10.1164/rccm.201703-0588UP. Review. No abstract available.

8.

Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories.

Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):1021-1030. doi: 10.1164/rccm.201703-0506OC.

9.

Feedback from the EBF - Focus Workshop: bringing assay validation and analysis of biomarkers into practice.

Timmerman P, Scheel Fjording M, Allinson J, Arfvidsson C, Barroso B, Diczfalusy U, Freeman A, Hickford E, Kandousi H, Katugampola S, Kunz U, Nelson R, Smeraglia J.

Bioanalysis. 2017 May;9(9):675-681. doi: 10.4155/bio-2017-0045. Epub 2017 May 18.

10.

AJRCCM: 100-Year Anniversary. Special Historical Image Section: Tuberculosis Then and Now.

Allinson JP, Mackay AJ, Shah PL.

Am J Respir Crit Care Med. 2017 May 1;195(9):1118-1123. doi: 10.1164/rccm.201702-0327IM. No abstract available.

PMID:
28459337
11.

The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud.

Cape S, Islam R, Nehls C, Allinson J, Safavi A, Bennett P, Hulse J, Beaver C, Khan M, Karnik S, Caturla MC, Lowes S, Iordachescu A, Silvestro L, Tayyem R, Shoup R, Mowery S, Keyhani A, Wakefield A, Li Y, Zimmer J, Torres J, Couerbe P, Khadang A, Bourdage J, Hughes N, Awaiye K, Matthews B, Fatmi S, Johnson R, Satterwhite C, Yu M, Lin J, Cojocaru L, Fiscella M, Thomas E, Kurylak K, Kamerud J, Lin ZJ, Garofolo W, Savoie N, Buonarati M, Boudreau N, Williard C, Liu Y, Warrino D, Kale P, Adcock N, Shekar R, O'Connor E, Ritzen H, Sanchez C, Hayes R, Bouhajib M, Savu SR, Stouffer B, Tabler E, Tu J, Briscoe C, der Strate BV, Rhyne P, Conliffe P, DuBey I, Yamashita J, Tang D, Groeber E, Vija J, Malone M, Osman M.

Bioanalysis. 2017 Apr;9(7):505-516. doi: 10.4155/bio-2017-5000. Epub 2017 Mar 24.

12.

2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity).

Richards S, Amaravadi L, Pillutla R, Birnboeck H, Torri A, Cowan KJ, Papadimitriou A, Garofolo F, Satterwhite C, Piccoli S, Wu B, Krinos-Fiorotti C, Allinson J, Berisha F, Cocea L, Croft S, Fraser S, Galliccia F, Gorovits B, Gupta S, Gupta V, Haidar S, Hottenstein C, Ishii-Watabe A, Jani D, Kadavil J, Kamerud J, Kramer D, Litwin V, Lima Santos GM, Nelson R, Ni Y, Pedras-Vasconcelos J, Qiu Y, Rhyne P, Safavi A, Saito Y, Savoie N, Scheibner K, Schick E, Siguenza PY, Smeraglia J, Staack RF, Subramanyam M, Sumner G, Thway T, Uhlinger D, Ullmann M, Vitaliti A, Welink J, Whiting CC, Xue L, Zeng R.

Bioanalysis. 2016 Dec;8(23):2475-2496.

13.

Physical activity and exercise capacity in patients with moderate COPD exacerbations.

Alahmari AD, Kowlessar BS, Patel AR, Mackay AJ, Allinson JP, Wedzicha JA, Donaldson GC.

Eur Respir J. 2016 Aug;48(2):340-9. doi: 10.1183/13993003.01105-2015. Epub 2016 Apr 28.

14.

The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development.

Allinson JP, Hardy R, Donaldson GC, Shaheen SO, Kuh D, Wedzicha JA.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):662-72. doi: 10.1164/rccm.201511-2210OC.

15.

2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity).

Amaravadi L, Song A, Myler H, Thway T, Kirshner S, Devanarayan V, Ni YG, Garofolo F, Birnboeck H, Richards S, Gupta S, Luo L, Kingsley C, Salazar-Fontana L, Fraser S, Gorovits B, Allinson J, Barger T, Chilewski S, Fjording MS, Haidar S, Islam R, Jaitner B, Kamerud J, Katori N, Krinos-Fiorotti C, Lanham D, Ma M, McNally J, Morimoto A, Mytych D, Nogueira da Costa A, Papadimitriou A, Pillutla R, Ray S, Safavi A, Savoie N, Schaefer M, Shih J, Smeraglia J, Skelly MF, Spond J, Staack RF, Stouffer B, Tampal N, Torri A, Welink J, Yang TY, Zoghbi J.

Bioanalysis. 2015 Dec;7(24):3107-24. doi: 10.4155/bio.15.226. Epub 2015 Dec 4.

16.

Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

Jani D, Allinson J, Berisha F, Cowan KJ, Devanarayan V, Gleason C, Jeromin A, Keller S, Khan MU, Nowatzke B, Rhyne P, Stephen L.

AAPS J. 2016 Jan;18(1):1-14. doi: 10.1208/s12248-015-9820-y. Epub 2015 Sep 16. Review.

17.

Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.

Brill SE, Law M, El-Emir E, Allinson JP, James P, Maddox V, Donaldson GC, McHugh TD, Cookson WO, Moffatt MF, Nazareth I, Hurst JR, Calverley PM, Sweeting MJ, Wedzicha JA.

Thorax. 2015 Oct;70(10):930-8. doi: 10.1136/thoraxjnl-2015-207194. Epub 2015 Jul 15.

18.

Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.

Donaldson GC, Law M, Kowlessar B, Singh R, Brill SE, Allinson JP, Wedzicha JA.

Am J Respir Crit Care Med. 2015 Oct 15;192(8):943-50. doi: 10.1164/rccm.201412-2269OC.

19.

Influence of weather and atmospheric pollution on physical activity in patients with COPD.

Alahmari AD, Mackay AJ, Patel AR, Kowlessar BS, Singh R, Brill SE, Allinson JP, Wedzicha JA, Donaldson GC.

Respir Res. 2015 Jun 13;16:71. doi: 10.1186/s12931-015-0229-z.

20.

Upper respiratory symptoms worsen over time and relate to clinical phenotype in chronic obstructive pulmonary disease.

Huerta A, Donaldson GC, Singh R, Mackay AJ, Allinson JP, Brill SE, Kowlessar B, Torres A, Wedzicha JA.

Ann Am Thorac Soc. 2015 Jul;12(7):997-1004. doi: 10.1513/AnnalsATS.201408-359OC.

21.

Ask the experts: method transfer.

James CA, Cheah TC, Perkins J, Allinson JL.

Bioanalysis. 2015;7(7):789-93. doi: 10.4155/bio.15.29.

PMID:
25932512
22.

7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing.

Rocci M, Lowes S, Shoup R, Garofolo F, Farmen R, Zhang T, Allinson J, Gouty D, Hayes R, Nicholson R, Houghton R, Dumont I, LeLacheur R, Zimmer J, Cruz Caturla M, Couerbe P, Awaiye K, Fatmi S, Sheldon C, Bower J, Fiscella M, Fast D, Cape S, Hulse J, Kamerud J, Pasas-Farmer S, Garofolo W, Moussallie M, Buonarati M, Boudreau N, Pellerin B, Lin J, Xu A, Bouhajib M, Stipancic M, Nehls C, Warren M, Karnik S, Stovold C, Reuschel S, Cojocaru L, Marcelletti J, Fang X, Smith I, Watson A.

Bioanalysis. 2014 Oct;6(20):2713-20. doi: 10.4155/bio.14.231. No abstract available.

23.

Recommendations on incurred sample stability (ISS) by GCC.

Lowes S, LeLacheur R, Shoup R, Garofolo F, Dumont I, Martinez S, Zimmer J, Caturla MC, Couerbe P, Awaiye K, Fatmi S, Farmen R, Sheldon C, Bower J, Fiscella M, Fast D, Cape S, Hulse J, Kamerud J, Zhang T, Pasas-Farmer S, Garofolo W, Moussallie M, Rocci M, Allinson J, Gouty D, Buonarati M, Boudreau N, Pellerin B, Lin J, Xu A, Hayes R, Bouhajib M, Stipancic M, Nicholson R, Nehls C, Warren M, Karnik S, Houghton R, Stovold C, Reuschel S, Cojocaru L, Marcelletti J, Fang X, Smith I, Watson A.

Bioanalysis. 2014 Sep;6(18):2385-90. doi: 10.4155/bio.14.155.

24.

Community-based recruitment of patients with COPD into clinical research.

Brill SE, El-Emir E, Allinson JP, Donaldson GC, Nazareth I, Wedzicha JA.

Thorax. 2014 Oct;69(10):951-2. doi: 10.1136/thoraxjnl-2014-205253. Epub 2014 Mar 4.

25.

Long-term antibiotic therapy reduces exacerbation frequency in patients with COPD but it remains unclear which patients to target.

Allinson JP, Donaldson GC.

Evid Based Med. 2014 Jun;19(3):99. doi: 10.1136/eb-2013-101711. Epub 2014 Feb 7. No abstract available.

PMID:
24510481
26.

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.

Wedzicha JA, Brill SE, Allinson JP, Donaldson GC.

BMC Med. 2013 Aug 14;11:181. doi: 10.1186/1741-7015-11-181. Review.

27.

Ask the experts: automation: part I.

Allinson JL, Blick KE, Cohen L, Higton D, Li M.

Bioanalysis. 2013 Aug;5(16):1953-62. doi: 10.4155/bio.13.181.

PMID:
23937129
28.

Recommendations on biomarker bioanalytical method validation by GCC.

Hougton R, Gouty D, Allinson J, Green R, Losauro M, Lowes S, LeLacheur R, Garofolo F, Couerbe P, Bronner S, Struwe P, Schiebl C, Sangster T, Pattison C, Islam R, Garofolo W, Pawula M, Buonarati M, Hayes R, Cameron M, Nicholson R, Harman J, Wieling J, De Boer T, Reuschel S, Cojocaru L, Harter T, Malone M, Nowatzke W.

Bioanalysis. 2012 Oct;4(20):2439-46. doi: 10.4155/bio.12.197.

29.

Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars.

Nicholson R, Lowes S, Caturla MC, Safavi A, Mamelak D, Islam R, Allinson J, Gouty D, Khan M, Lelacheur R, Shoup R, Martinez S, Dumont I, Zimmer J, Steffen R, Petrilla J, Awaiye K, Sheldon C, Turk D, Fast D, Kamerud J, Dinan A, Lin ZJ, Garofolo W, Tang D, Wright L, Lin J, Yamashita Y, Liu Y, Xu A, Hayes R, Bouhajib M, Levesque A, Gagnon-Carignan S, Harman J, Warren M, Karnik S, Cojocaru L, Reuschel S, Gonzalez P, Fatmi S, Vija J, Rock M, Malone M, Nowatzke W, Fang X.

Bioanalysis. 2012 Oct;4(19):2335-42. doi: 10.4155/bio.12.213. No abstract available.

30.

Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC).

Lowes S, Boterman M, Doig M, Breda M, Jersey J, Lelacheur R, Shoup R, Garofolo F, Dumont I, Martinez S, Needham S, Zimmer J, Caturla MC, Couerbe P, Maltas J, Steffen R, Petrilla J, Safavi A, Awaiye K, Bhatti M, Sheldon C, Schiebl C, Struwe P, Turk D, Sangster T, Pattison C, Fast D, Goodwin L, Kamerud J, Dinan A, Mamelak D, Islam R, Segers R, Lin ZJ, Hillier J, Garofolo W, Folguera L, Zimmer D, Zimmermann T, Pawula M, Moussallie M, de Souza Teixeira L, Rocha T, Allinson J, Jardieu P, Tang D, Gouty D, Wright L, Truog J, Lin J, Yamashita Y, Khan M, Liu Y, Xu A, Lundberg R, Cox C, Breau A, Hayes R, Bigogno C, Schoutsen D, Dilger C, Jonker J, Bouhajib M, Levesque A, Gagnon-Carignan S, Harman J, Nicholson R, Jenkins R, Warren M, Lin MH, Karnik S, De Boer T, Houghton R, Green R, Demaio W, Sable R, Smith K, Siethoff C, Cojocaru L, Allen M, Reuschel S, Gonzalez P, Harter T, Fatmi S, Rock M, Vija J, Sayyarpour F, Malone M, Nowatzke W, Best S, Fang X.

Bioanalysis. 2012 Sep;4(17):2117-26.

31.

Sulphadiazine-induced obstructive renal failure complicating treatment of HIV-associated toxoplasmosis.

Allinson J, Topping W, Edwards SG, Miller RF.

Int J STD AIDS. 2012 Mar;23(3):210-2. doi: 10.1258/ijsa.2009.009539.

PMID:
22581877
32.

Automated immunoassay equipment platforms for analytical support of pharmaceutical and biopharmaceutical development.

Allinson JL.

Bioanalysis. 2011 Dec;3(24):2803-16. doi: 10.4155/bio.11.209. Review.

PMID:
22185280
33.

Fit-for-purpose method development and validation for successful biomarker measurement.

Lee JW, Devanarayan V, Barrett YC, Weiner R, Allinson J, Fountain S, Keller S, Weinryb I, Green M, Duan L, Rogers JA, Millham R, O'Brien PJ, Sailstad J, Khan M, Ray C, Wagner JA.

Pharm Res. 2006 Feb;23(2):312-28. Epub 2006 Jan 12.

PMID:
16397743
34.

The effects of packaging on the stability of a moisture sensitive compound.

Allinson JG, Dansereau RJ, Sakr A.

Int J Pharm. 2001 Jun 19;221(1-2):49-56.

PMID:
11397566

Supplemental Content

Loading ...
Support Center